The U.S. Food and Drug Administration’s Oncology Center of Excellence (OCE) Pediatric Oncology Program invites members of the pediatric cancer advocacy community to participate in the 2024 OCE Pediatric Advocacy Forum on October 15. The purpose of this event is to strengthen collaboration and promote more efficient development of new, safe, and effective drugs and biological products for pediatric patients with cancer.
This forum will feature brief presentations by FDA scientists on topics of interest to the community, followed by informal discussion. Time will also be dedicated to a listening session for advocacy members to provide perspectives on topics of their choice, as well as networking for those who attend in person.
The OCE Pediatric Advocacy Forum will be held from 9 AM to 1 PM EST. Attendance can be in-person at the FDA White Oak Campus in Silver Spring, Maryland, or virtual.
Visit the Pediatric Advocacy Forum web page for further information and to register to attend.
